For decades, breast cancer survivors going through menopause have been told that hormone therapy is off-limits—full stop. But new analyses and a 2025 expert consensus paper suggest that there may be ...

Odds are you know someone who has had breast cancer, or maybe you're even a survivor yourself. But what if we told you there ...

Giredestrant shows significant improvement in iDFS in patients with early-stage, HR-positive, HER2-negative breast cancer.

Hormone therapy for breast cancer slows or stops the growth of hormone-sensitive tumors and is not the same as hormone replacement therapy.

The HRT Trial was launched in March 2002 and had recruited 197 patients from 32 UK hospitals. The primary aim is to assess the effect of HRT on the long-term disease free and overall survival of ...

Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...